# OnCo record corcept (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/corcept/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "corcept" ;
  schema:name "Corcept Therapeutics"@en ;
  schema:description "Corcept is a cortisol-modulation company whose relacorilant was approved in ovarian cancer in 2026."@en ;
  schema:url <https://onco.cc/companies/corcept/>, <https://www.corcept.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Corcept_Therapeutics> ;
  owl:sameAs <http://www.wikidata.org/entity/Q15734041> ;
  schema:citation <https://www.corcept.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/relacorilant/> ;
  onco:trials <https://onco.cc/trials/nct07259317/>, <https://onco.cc/trials/nct06906341/>, <https://onco.cc/trials/nct07276373/> .